Why do we have trustees?
Trustees are the people who form the governing body of a charity. They are the people who are ultimately responsible for directing the business of the charity. Their work is voluntary, and they receive no payment.
Isla Smith – Chair
Isla’s background is in law. Having qualified as a lawyer in South Africa and England, she became a Commercial Tax Partner with international law firm Norton Rose, where she was also a member of the management board and Global Head of Tax. She left in 2004 to establish a portfolio of non-executive directorships in the commercial and charity sectors.
Chris is a chartered accountant, formerly Head of Finance at the Biochemical Society, a scientific charitable learned society, and previously at the Crafts Council, a government funded charity. Chris’s wife has breast cancer and frequently acts as a spokesperson for the charity. She is also a lay member involved in the development of the Breast Cancer Campaign Tissue Bank.
Hunada is Finance Director General at the Department for Work and Pensions, after three years as Director General Finance and Corporate Services at the Department for Communities and Local Government, and has a strong record of delivering world-class performance and change in major private and public sector organisations. Hunada has been treated for breast cancer.
Laura is an independent consultant in strategic communications who works principally in the not-for-profit sector. Her previous roles span various communications and campaigning posts in a range of consumer-focused organisations. Laura has been treated for breast cancer and acts as a spokesperson for the charity.
Professor Alastair Thompson ALCM BSc (Hons) MBChB MD FRCSEd (Gen)
Alastair is Professor of Surgical Oncology at the University of Dundee, Director of Tayside Clinical Research Centre, Experimental Cancer Medicine Lead for Dundee and Director of Breast Cancer Research for the East of Scotland and Professor of Surgical Oncology. He is a surgeon and was formerly Chair of Breast Cancer Campaign's Scientific Advisory Board. He is also Chair of the Breast Cancer Campaign Tissue Bank Management Board.
Shoba is editorial director/co-founder of publishing company Splendid Books. She began her career in journalism, helping to launch Sky Television and working for five years at The Sun newspaper, before juggling life as a hands-on mother to three children with freelance journalism, marketing and publicity.
Veronique is a consultant and coach in the Lifesciences sector and a non-executive Director of International Biotechnnology Trust PLC. Prior to this she was Director of Corporate Strategy and Head of Venture Capital Relations at AstraZeneca. Her broad professional experience across varied functions and healthcare sectors includes drug development, venture capital and business development as well as clinical posts in British teaching hospitals.
Pascale is founder and CEO of Shelley Capital, a hedge fund advisory company, and has 20 years' experience as an investment banker in the City of London. Pascale has been treated for breast cancer.
Professor Robert Coleman, Department of Oncology, University of Sheffield
Professor Coleman leads a large clinical research team and is Director of the Gestational Trophoblastic Diseases Treatment Centre in Sheffield. Since 2011, he has been an Associate Director of the National Cancer Research Network (NCRN). He is also the lead for the new CR-UK / YCR Sheffield Cancer Centre.
As research lead for clinical cancer research he is responsible for running the Cancer Clinical Trials Centre, a purpose built clinical research facility that provides the research infrastructure for the North Trent Cancer Research Network, the Experimental Cancer Medicine Centre, and the breast cancer component of the bone oncology research laboratories within the medical school.
Dr Sue Eccles
Dr Suzanne Eccles is a basic research scientist interested in the cellular and molecular mechanisms of metastasis and angiogenesis. She is currently a Reader in Tumour Biology in the Division of Cancer Therapeutics at the Institute of Cancer Research, Sutton. Sue sat on Campaign’s SAB from May 2003 to November 2011. During this eight year period, Campaign supported 296 grants worth over £32 million. Since the end of her tenure on the SAB, Sue joined the Board of Trustees and is acting, alongside Professor Alastair Thompson, as co-Chair of Campaign’s 2012 Gap Analysis Refresh.